Forma Medical is making innovative advancements in orthopedic surgery techniques and medical devices. Their patented “Silver Bullet” component allows surgeons to accurately visualize implant placement during minimally invasive procedures like hammertoe and bunion surgeries, contributing to Forma’s comprehensive IP portfolio.

Forma Medical’s groundbreaking technology reduces the need for large incisions, eliminates the need for painful wires, minimizes scarring, reduces swelling, and accelerates recovery time. This approach allows patients to attain their desired hammertoe correction through a significantly less invasive surgery, resulting in better overall outcomes and enhanced patient satisfaction.

Forma’s mission centers on three pillars: driving rapid innovation with speed to market, providing cost-effective surgical solutions, and promoting less invasive techniques that minimize patient trauma and recovery times. From innovative implant designs to advanced surgical instruments, they continuously explore new ways to make orthopedic procedures less disruptive and improve outcomes for patients. Forma’s cutting-edge products like Optimal HT and Optimal Akin are setting new standards for minimally invasive hammertoe and bunion repair surgeries.

“Ben Franklin’s investment and support was crucial for getting us off the ground,” said Andrew Davison, Chairman and CEO of Forma Medical. “It allowed us to hire staff, register with the FDA, obtain product clearances, build inventory, and launch our first device, Optimal HT.” The team at Forma Medical also credits support from partners like Ben Franklin Technology Partners as profoundly impactful drivers of their growth journey. For entrepreneurs, “Ben Franklin serves as an amazing starting point for guidance.”

LEARN MORE ABOUT THEIR JOURNEY AT FORMAMEDICAL.COM